SEC Info - Aligos Therapeutics, Inc. - ‘S-8’ on 3/12/24

SEC Info℠

Home

Help

Please Sign In

Aligos Therapeutics, Inc. – ‘S-8’ on 3/12/24 – ‘EX-23.2’

On: Tuesday, 3/12/24, at 4:51pm ET · Effective: 3/12/24 · Accession #: 1193125-24-65970 · File #: 333-277860

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/12/24  Aligos Therapeutics, Inc.         S-8         3/12/24    4:89K                                    Donnelley … Solutions/FA

Registration Statement – Securities for an Employee Benefit Plan — Form S-8 — SA’33

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-8         Registration Statement - Securities for an          HTML     47K 
                Employee Benefit Plan                                            
 2: EX-5.1      Opinion of Counsel re: Legality                     HTML     12K 
 3: EX-23.2     Consent of Expert or Counsel                        HTML      5K 
 4: EX-FILING FEES  Filing Fees                                     HTML     18K

‘EX-23.2’ — Consent of Expert or Counsel

This Exhibit is an HTML Document rendered as filed. [ Alternative Formats ]

EX-23.2

Exhibit 23.2

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the Registration Statement (Form S-8) pertaining to the 2020 Incentive Award Plan and 2020 Employee Stock Purchase Plan of Aligos Therapeutics, Inc. of our report dated March 12, 2024, with respect to the consolidated financial statements of Aligos Therapeutics, Inc. included in the Annual Report (Form 10-K) for the year ended December 31, 2023, filed with the Securities and Exchange Commission.

/s/ Ernst & Young LLP

San Mateo, California

March 12, 2024

Dates Referenced Herein and Documents Incorporated by Reference

This ‘S-8’ Filing	Date	Other Filings

Filed on / Effective on:	3/12/24	10-K, 8-K
	12/31/23	10-K
		List all Filings

10 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/12/24  Aligos Therapeutics, Inc.         10-K       12/31/23   91:11M                                    Donnelley … Solutions/FA
10/25/23  Aligos Therapeutics, Inc.         8-K:1,3,9  10/23/23   13:599K                                   Donnelley … Solutions/FA
 3/09/23  Aligos Therapeutics, Inc.         S-8         3/09/23    4:85K                                    Donnelley … Solutions/FA
 3/10/22  Aligos Therapeutics, Inc.         S-8         3/10/22    4:82K                                    Donnelley … Solutions/FA
 3/23/21  Aligos Therapeutics, Inc.         10-K       12/31/20   91:16M                                    ActiveDisclosure/FA
 3/23/21  Aligos Therapeutics, Inc.         S-8         3/23/21    3:72K                                    Donnelley … Solutions/FA
10/20/20  Aligos Therapeutics, Inc.         S-8        10/20/20    3:108K                                   Donnelley … Solutions/FA
10/20/20  Aligos Therapeutics, Inc.         8-K:5,8,9  10/20/20    3:234K                                   Donnelley … Solutions/FA
10/13/20  Aligos Therapeutics, Inc.         8-A12B                 1:14K                                    Donnelley … Solutions/FA
10/09/20  Aligos Therapeutics, Inc.         S-1/A                 19:8.9M                                   Donnelley … Solutions/FA

↑Top

Filing Submission 0001193125-24-065970 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)